Evidence map›Paper›PMID 35420796›Full record

ArticleACS nano2022

Optical Nanosensor for Intracellular and Intracranial Detection of Amyloid-Beta.

Merav Antman-Passig, Eitan Wong, Georgia R Frost, Christian Cupo, Janki Shah, Albert Agustinus, Ziyu Chen, Chiara Mancinelli, Maikel Kamel, Thomas Li and 3 more

Abstract read
In one paragraph

Article in ACS nano, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. High-throughput SWCNT NIR-II screening enables cell andbioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Merav Antman-PassigMolecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.ORCID 0000-0003-2102-9139
Eitan WongChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Georgia R FrostChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Christian CupoDepartment of Mechanical Engineering, Columbia University, New York, New York 10027, United States.
Janki ShahMolecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Albert AgustinusProgram of Pharmacology, Weill Graduate School of Medical Sciences of Cornell University, New York, New York 10065, United States.
Ziyu ChenProgram of Physiology, Biophysics, & Systems Biology, Weill Graduate School of Medical Sciences of Cornell University, New York, New York 10065, United States.
Chiara MancinelliProgram of Pharmacology, Weill Graduate School of Medical Sciences of Cornell University, New York, New York 10065, United States.
Maikel KamelSophie Davis School of Biomedical Education, CUNY School of Medicine, New York, New York 10031, United States.
Thomas LiChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Lauren A JonasChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Yue-Ming LiChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.ORCID 0000-0002-2633-3730
Daniel A HellerMolecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.ORCID 0000-0002-6866-0000

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Regulation of y-secretase activity by modulatory proteinsR01AG061350 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI LI, YUEMING · 2019 to 2023
$4.3M
Tumor-Selective Delivery Approaches for MedulloblastomaR01NS116353 · NINDS · SLOAN-KETTERING INST CAN RESEARCH · PI HELLER, DANIEL ALAN, RAJU, PRAVEEN B. · 2020 to 2024
$3.1M
NCI NIH HHS P30 CA008748NIA NIH HHS R01 AG061350NINDS NIH HHS R01 NS116353
6 · The paper itself

Abstract

Amyloid-beta (Aβ) deposition occurs in the early stages of Alzheimer's disease (AD), but the early detection of Aβ is a persistent challenge. Herein, we engineered a near-infrared optical nanosensor capable of detecting Aβ intracellularly in live cells and intracranially in vivo. The sensor is composed of single-walled carbon nanotubes functionalized with Aβ wherein Aβ-Aβ interactions drive the response. We found that the Aβ nanosensors selectively responded to Aβ via solvatochromic modulation of the near-infrared emission of the nanotube. The sensor tracked Aβ accumulation in live cells and, upon intracranial administration in a genetic model of AD, signaled distinct responses in aged mice. This technology enables the interrogation of molecular mechanisms underlying Aβ neurotoxicity in the development of AD in living systems.

Indexed as

Alzheimer DiseaseNanotubes, CarbonAmyloid beta-PeptidesAnimalsMiceAmyloid beta-PeptidesNanotubes, Carbonbiosensorcarbon nanomaterialsfluorescencenanocarbonneurodegenerative disease

Identifiers

PMID35420796
PMCPMC9710299

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.